Ascendis Pharma A/S (ASND)
USD 156.67
(-0.93%)
USD 156.67
(-0.93%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -438.16 Million EUR | 16.91% |
| 2022 | -556.04 Million EUR | -24.47% |
| 2021 | -423.66 Million EUR | -28.82% |
| 2020 | -328.88 Million EUR | -51.54% |
| 2019 | -217.02 Million EUR | -44.51% |
| 2018 | -150.17 Million EUR | -36.67% |
| 2017 | -109.88 Million EUR | -52.36% |
| 2016 | -72.12 Million EUR | -74.82% |
| 2015 | -33.01 Million EUR | -259.2% |
| 2014 | -11.48 Million EUR | -302.06% |
| 2013 | 5.68 Million EUR | 193.29% |
| 2012 | 1.73 Million EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -46.88 Million EUR | 30.73% |
| 2024 Q2 | -129.52 Million EUR | -86.63% |
| 2023 Q4 | -67.68 Million EUR | 48.85% |
| 2023 FY | - EUR | 16.91% |
| 2023 Q1 | -95.23 Million EUR | 46.09% |
| 2023 Q2 | -107.88 Million EUR | -13.29% |
| 2023 Q3 | -132.31 Million EUR | -22.65% |
| 2022 Q4 | -176.64 Million EUR | -43.2% |
| 2022 Q3 | -123.36 Million EUR | -82.64% |
| 2022 Q1 | -115.44 Million EUR | -14.79% |
| 2022 Q2 | -67.54 Million EUR | 41.49% |
| 2022 FY | - EUR | -24.47% |
| 2021 Q3 | -75.68 Million EUR | 36.23% |
| 2021 FY | - EUR | -28.82% |
| 2021 Q2 | -118.68 Million EUR | -103.22% |
| 2021 Q1 | -58.4 Million EUR | 66.53% |
| 2021 Q4 | -100.57 Million EUR | -32.88% |
| 2020 Q3 | -79.52 Million EUR | 3.67% |
| 2020 Q4 | -174.46 Million EUR | -119.4% |
| 2020 FY | - EUR | -51.54% |
| 2020 Q2 | -82.54 Million EUR | -35.43% |
| 2020 Q1 | -60.95 Million EUR | 23.8% |
| 2019 Q1 | -52.21 Million EUR | -64.5% |
| 2019 FY | - EUR | -44.51% |
| 2019 Q4 | -79.99 Million EUR | -249.46% |
| 2019 Q3 | -22.89 Million EUR | 53.26% |
| 2019 Q2 | -48.97 Million EUR | 6.22% |
| 2018 FY | - EUR | -36.67% |
| 2018 Q4 | -31.74 Million EUR | 6.06% |
| 2018 Q2 | -22.67 Million EUR | 33.85% |
| 2018 Q1 | -34.27 Million EUR | 23.55% |
| 2018 Q3 | -33.79 Million EUR | -49.05% |
| 2017 Q3 | -31.12 Million EUR | -27.91% |
| 2017 FY | - EUR | -52.36% |
| 2017 Q1 | -23.26 Million EUR | -20.16% |
| 2017 Q2 | -24.32 Million EUR | -4.59% |
| 2017 Q4 | -44.83 Million EUR | -44.06% |
| 2016 Q4 | -19.35 Million EUR | -8.79% |
| 2016 FY | - EUR | -74.82% |
| 2016 Q1 | -17.71 Million EUR | -19.15% |
| 2016 Q3 | -17.79 Million EUR | -34.95% |
| 2016 Q2 | -13.18 Million EUR | 25.54% |
| 2015 Q1 | 1.6 Million EUR | 127.81% |
| 2015 Q4 | -14.86 Million EUR | -110.96% |
| 2015 Q3 | -7.04 Million EUR | 44.52% |
| 2015 Q2 | -12.7 Million EUR | -893.75% |
| 2015 FY | - EUR | -259.2% |
| 2014 Q1 | -343 Thousand EUR | -119.86% |
| 2014 Q3 | -1.77 Million EUR | 9.37% |
| 2014 Q2 | -1.95 Million EUR | -469.39% |
| 2014 FY | - EUR | -302.06% |
| 2014 Q4 | -5.75 Million EUR | -225.08% |
| 2013 Q3 | 1.86 Million EUR | 164.59% |
| 2013 Q1 | 706 Thousand EUR | 0.0% |
| 2013 FY | - EUR | 193.29% |
| 2013 Q4 | 1.72 Million EUR | -7.55% |
| 2013 Q2 | 706 Thousand EUR | 0.0% |
| 2012 FY | - EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Eton Pharmaceuticals, Inc. | -291 Thousand USD | -150473.196% |
| TRACON Pharmaceuticals, Inc. | -6.88 Million USD | -6265.02% |
| Vaxxinity, Inc. | -56.05 Thousand USD | -781630.924% |
| IO Biotech, Inc. | -91.22 Million USD | -380.3% |
| Aridis Pharmaceuticals, Inc. | -29.5 Million USD | -1385.013% |
| CASI Pharmaceuticals, Inc. | -21.53 Million USD | -1934.301% |
| MEI Pharma, Inc. | 26.38 Million USD | 1760.986% |
| Mersana Therapeutics, Inc. | -166.08 Million USD | -163.829% |
| Phathom Pharmaceuticals, Inc. | -159.04 Million USD | -175.492% |
| SELLAS Life Sciences Group, Inc. | 529 Thousand USD | 82929.49% |
| Syndax Pharmaceuticals, Inc. | -229.94 Million USD | -90.556% |
| Keros Therapeutics, Inc. | -152.17 Million USD | -187.933% |
| Telomir Pharmaceuticals, Inc. Common Stock | -6.11 Million USD | -7063.651% |
| Adaptive Biotechnologies Corporation | -189.27 Million USD | -131.501% |
| Agenus Inc. | -145.92 Million USD | -200.271% |
| AlloVir, Inc. | -190.14 Million USD | -130.438% |
| CRISPR Therapeutics AG | -202.7 Million USD | -116.165% |
| Xeris Biopharma Holdings, Inc. | -23.73 Million USD | -1746.084% |
| NextCure, Inc. | -59.03 Million USD | -642.167% |
| Opthea Limited | -200.01 Million USD | -119.063% |
| Outlook Therapeutics, Inc. | -57.37 Million USD | -663.679% |
| Rigel Pharmaceuticals, Inc. | -16.98 Million USD | -2480.343% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -1717.227% |
| Aadi Bioscience, Inc. | -65.36 Million USD | -570.34% |
| Senti Biosciences, Inc. | -61.33 Million USD | -614.373% |
| Akebia Therapeutics, Inc. | -6.86 Million USD | -6279.849% |
| Alzamend Neuro, Inc. | -9.88 Million USD | -4331.801% |
| Alnylam Pharmaceuticals, Inc. | -258.24 Million USD | -69.673% |
| BioLineRx Ltd. | -57.06 Million USD | -667.894% |
| Compass Therapeutics, Inc. | -48.47 Million USD | -803.942% |
| Barinthus Biotherapeutics plc | -74.81 Million USD | -485.67% |
| Sensei Biotherapeutics, Inc. | -33.38 Million USD | -1212.43% |
| Janux Therapeutics, Inc. | -71.02 Million USD | -516.929% |
| Verrica Pharmaceuticals Inc. | -62.19 Million USD | -604.484% |
| AbCellera Biologics Inc. | -192.15 Million USD | -128.025% |
| ADMA Biologics, Inc. | 5.12 Million USD | 8657.969% |
| Aptorum Group Limited | -9.59 Million USD | -4464.727% |
| AnaptysBio, Inc. | -143.16 Million USD | -206.06% |
| Ardelyx, Inc. | -55.35 Million USD | -691.574% |
| Arrowhead Pharmaceuticals, Inc. | -175.67 Million USD | -149.424% |
| Bicycle Therapeutics plc | -183.4 Million USD | -138.914% |
| BioXcel Therapeutics, Inc. | -165.42 Million USD | -164.881% |
| C4 Therapeutics, Inc. | -122.1 Million USD | -258.851% |
| Clearside Biomedical, Inc. | -23.05 Million USD | -1800.286% |
| Chimerix, Inc. | -92.97 Million USD | -371.28% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.43 Million USD | -886.05% |
| Dyadic International, Inc. | -8.22 Million USD | -5224.203% |
| Elevation Oncology, Inc. | -41.46 Million USD | -956.667% |
| ESSA Pharma Inc. | -26.45 Million USD | -1556.257% |
| Fortress Biotech, Inc. | -133.64 Million USD | -227.865% |
| Fate Therapeutics, Inc. | -172.22 Million USD | -154.41% |
| GlycoMimetics, Inc. | -39.12 Million USD | -1020.004% |
| Fortress Biotech, Inc. | -133.64 Million USD | -227.865% |
| ChromaDex Corporation | -3.89 Million USD | -11152.388% |
| Hoth Therapeutics, Inc. | -153.14 Thousand USD | -286005.688% |
| CARGO Therapeutics, Inc. Common Stock | -93.01 Million USD | -371.057% |
| Caribou Biosciences, Inc. | -112.53 Million USD | -289.365% |
| IDEAYA Biosciences, Inc. | -130.42 Million USD | -235.964% |
| Inhibrx Biosciences, Inc. | -206.69 Million USD | -111.99% |
| Incyte Corporation | 919.42 Million USD | 147.657% |
| Inovio Pharmaceuticals, Inc. | -130.39 Million USD | -236.042% |
| Intensity Therapeutics, Inc. | -10.08 Million USD | -4244.319% |
| Jaguar Health, Inc. | -33.13 Million USD | -1222.532% |
| Jazz Pharmaceuticals plc | 1.44 Billion USD | 130.231% |
| Kintara Therapeutics, Inc. | -8.39 Million USD | -5118.771% |
| Ligand Pharmaceuticals Incorporated | 101.72 Million USD | 530.729% |
| ContextLogic Inc. | -324 Million USD | -35.237% |
| Lantern Pharma Inc. | -15.78 Million USD | -2675.554% |
| Madrigal Pharmaceuticals, Inc. | -379.96 Million USD | -15.317% |
| MiMedx Group, Inc. | 40.51 Million USD | 1181.442% |
| Marinus Pharmaceuticals, Inc. | -125.49 Million USD | -249.146% |
| Structure Therapeutics Inc. | -102.45 Million USD | -327.652% |
| HOOKIPA Pharma Inc. | -77.34 Million USD | -466.526% |
| Onconetix, Inc. | -36.7 Million USD | -1093.7% |
| Oncternal Therapeutics, Inc. | 2.23 Million USD | 19704.832% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -15824.233% |
| PDS Biotechnology Corporation | -40.08 Million USD | -993.098% |
| Precigen, Inc. | -89.22 Million USD | -391.077% |
| Pharming Group N.V. | 9.87 Million USD | 4536.246% |
| Pieris Pharmaceuticals, Inc. | -22.76 Million USD | -1824.998% |
| PureTech Health plc | -11.62 Million USD | -3668.539% |
| RAPT Therapeutics, Inc. | -125.84 Million USD | -248.178% |
| Royalty Pharma plc | 1.88 Billion USD | 123.217% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -1717.227% |
| Seer, Inc. | -97.88 Million USD | -347.635% |
| Sangamo Therapeutics, Inc. | -87.42 Million USD | -401.182% |
| Sol-Gel Technologies Ltd. | -28.96 Million USD | -1412.854% |
| Acelyrin, Inc. | -381.52 Million USD | -14.846% |
| Salarius Pharmaceuticals, Inc. | -12.88 Thousand USD | -3400534.386% |
| Pyxis Oncology, Inc. | -78.49 Million USD | -458.226% |
| TransCode Therapeutics, Inc. | -17.97 Million USD | -2337.863% |
| Syros Pharmaceuticals, Inc. | -157.19 Million USD | -178.742% |
| TG Therapeutics, Inc. | 26.1 Million USD | 1778.805% |
| Alkermes plc | 495.04 Million USD | 188.51% |
| Entrada Therapeutics, Inc. | -321 Thousand USD | -136400.935% |
| Titan Pharmaceuticals, Inc. | -7.16 Million USD | -6015.394% |
| Orchestra BioMed Holdings, Inc. | -51.21 Million USD | -755.479% |
| Ocuphire Pharma, Inc. | -9.96 Million USD | -4295.746% |
| VistaGen Therapeutics, Inc. | -32.45 Million USD | -1250.162% |
| Wave Life Sciences Ltd. | -58.79 Million USD | -645.31% |
| Avidity Biosciences, Inc. | -233.49 Million USD | -87.655% |
| Geron Corporation | -174.78 Million USD | -150.694% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -2073.56% |
| Summit Therapeutics Inc. | 1 Million USD | 43873.027% |
| Stoke Therapeutics, Inc. | -112.3 Million USD | -290.162% |
| Alaunos Therapeutics, Inc. | -30.9 Million USD | -1317.836% |
| Inhibikase Therapeutics, Inc. | -19.91 Million USD | -2100.479% |
| Innoviva, Inc. | 248.96 Million USD | 275.999% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -672.048% |
| Vaxcyte, Inc. | -464.88 Million USD | 5.747% |
| Molecular Templates, Inc. | 1.43 Million USD | 30741.119% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -1397.601% |
| Sorrento Therapeutics, Inc. | -539.92 Million USD | 18.847% |
| Viracta Therapeutics, Inc. | -46.86 Million USD | -835.018% |
| Novavax, Inc. | -487.39 Million USD | 10.099% |
| eFFECTOR Therapeutics, Inc. | -33.73 Million USD | -1198.93% |
| Scopus BioPharma Inc. | -11.71 Million USD | -3640.822% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 604.732% |
| Precision BioSciences, Inc. | -32.04 Million USD | -1267.48% |
| GT Biopharma, Inc. | 5.97 Million USD | 7428.45% |
| ImmuCell Corporation | -2.5 Million USD | -17398.184% |
| Immix Biopharma, Inc. | -16.13 Million USD | -2615.528% |
| Mesoblast Limited | -61.33 Million USD | -614.432% |
| Rocket Pharmaceuticals, Inc. | -236.62 Million USD | -85.176% |
| Aptose Biosciences Inc. | -52.26 Million USD | -738.31% |
| ZyVersa Therapeutics, Inc. | -107.74 Million USD | -306.677% |
| Soligenix, Inc. | -7.85 Million USD | -5479.732% |
| Century Therapeutics, Inc. | -121.2 Million USD | -261.501% |
| Kura Oncology, Inc. | -164.95 Million USD | -165.629% |
| TScan Therapeutics, Inc. | -80.09 Million USD | -447.04% |
| Ocean Biomedical, Inc. | -957.73 Thousand USD | -45650.251% |
| CytomX Therapeutics, Inc. | -4.3 Million USD | -10068.67% |
| Autolus Therapeutics plc | -156.77 Million USD | -179.497% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -417.58% |
| EyePoint Pharmaceuticals, Inc. | -69 Million USD | -535.017% |
| Eterna Therapeutics Inc. | -19.93 Million USD | -2098.094% |
| GRI Bio, Inc. | -10.89 Million USD | -3920.628% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -9603.181% |
| Tenaya Therapeutics, Inc. | -122.5 Million USD | -257.671% |
| IGM Biosciences, Inc. | -253.35 Million USD | -72.944% |
| INmune Bio, Inc. | - USD | Infinity% |
| Heron Therapeutics, Inc. | -103.79 Million USD | -322.16% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -1049.045% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -2758.07% |
| Entero Therapeutics, Inc. | -15.74 Million USD | -2683.213% |
| Milestone Pharmaceuticals Inc. | -56.84 Million USD | -670.812% |
| X4 Pharmaceuticals, Inc. | -107.1 Million USD | -309.109% |
| Atara Biotherapeutics, Inc. | -265.99 Million USD | -64.727% |
| Coherus BioSciences, Inc. | -193.93 Million USD | -125.931% |
| Verastem, Inc. | -83.16 Million USD | -426.86% |
| Abeona Therapeutics Inc. | -50.57 Million USD | -766.424% |
| Pliant Therapeutics, Inc. | -158.22 Million USD | -176.922% |
| Tonix Pharmaceuticals Holding Corp. | -114.08 Million USD | -284.058% |
| Histogen Inc. | -10.5 Million USD | -4071.837% |
| Aprea Therapeutics, Inc. | -14.27 Million USD | -2968.466% |
| Surrozen, Inc. | -41.13 Million USD | -965.299% |
| Organovo Holdings, Inc. | -14.8 Million USD | -2859.395% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 13662962.488% |
| Ovid Therapeutics Inc. | -58.71 Million USD | -646.286% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -754.229% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.33 Million USD | -5155.07% |
| Centessa Pharmaceuticals plc | -166.06 Million USD | -163.851% |
| Hepion Pharmaceuticals, Inc. | -49.25 Million USD | -789.528% |
| Arcturus Therapeutics Holdings Inc. | -24.16 Million USD | -1713.159% |
| BioRestorative Therapies, Inc. | -15.05 Million USD | -2810.441% |
| Apollomics, Inc. | -171.74 Million USD | -155.124% |
| Amarin Corporation plc | -50.9 Million USD | -760.815% |
| Turnstone Biologics Corp. | -56.23 Million USD | -679.187% |
| Kymera Therapeutics, Inc. | -143.2 Million USD | -205.981% |
| Synaptogenix, Inc. | -8.3 Million USD | -5174.362% |
| Tiziana Life Sciences Ltd | -15.33 Million USD | -2756.562% |
| Aurinia Pharmaceuticals Inc. | -63.04 Million USD | -594.986% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -9044.759% |
| Monopar Therapeutics Inc. | 429.03 Thousand USD | 102227.779% |
| Exelixis, Inc. | 196.6 Million USD | 322.871% |
| Better Therapeutics, Inc. | -38.26 Million USD | -1045.178% |
| Nurix Therapeutics, Inc. | -141.4 Million USD | -209.859% |
| Apellis Pharmaceuticals, Inc. | -495.21 Million USD | 11.519% |
| NLS Pharmaceutics AG | -11.79 Million USD | -3614.656% |
| Dermata Therapeutics, Inc. | 247.21 Thousand USD | 177340.955% |
| Gritstone bio, Inc. | -126.86 Million USD | -245.387% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -574.26% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -10854.348% |
| Avid Bioservices, Inc. | -11.48 Million USD | -3716.462% |
| Insmed Incorporated | -654.73 Million USD | 33.077% |
| Virpax Pharmaceuticals, Inc. | -2.24 Million USD | -19376.566% |
| MediWound Ltd. | -4.89 Million USD | -8854.997% |
| OmniAb, Inc. | -49.73 Million USD | -781.076% |
| Alector, Inc. | -142.89 Million USD | -206.643% |
| Seres Therapeutics, Inc. | -85.43 Million USD | -412.873% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -740.239% |
| Zai Lab Limited | -366.57 Million USD | -19.531% |
| Revance Therapeutics, Inc. | -290.63 Million USD | -50.761% |
| Aura Biosciences, Inc. | -83.69 Million USD | -423.523% |
| Lyell Immunopharma, Inc. | -225.24 Million USD | -94.526% |
| Immunic, Inc. | -99.11 Million USD | -342.094% |
| Tarsus Pharmaceuticals, Inc. | -131.67 Million USD | -232.777% |
| Veracyte, Inc. | -49.4 Million USD | -786.818% |
| InMed Pharmaceuticals Inc. | -7.06 Million USD | -6102.892% |
| FibroGen, Inc. | -261.4 Million USD | -67.62% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -3832.932% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -6158.356% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.71 Million USD | -2241.033% |
| Cyclacel Pharmaceuticals, Inc. | -25.42 Million USD | -1623.578% |
| Amylyx Pharmaceuticals, Inc. | 39.89 Million USD | 1198.441% |
| Galecto, Inc. | -37.51 Million USD | -1067.856% |
| Calithera Biosciences, Inc. | -38.26 Million USD | -1045.088% |
| Fortrea Holdings Inc. | 167.3 Million USD | 361.906% |
| KalVista Pharmaceuticals, Inc. | -134.28 Million USD | -226.309% |
| Aptevo Therapeutics Inc. | -28.31 Million USD | -1447.695% |
| XBiotech Inc. | -35.76 Million USD | -1125.096% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -574.26% |
| Lyra Therapeutics, Inc. | -65.25 Million USD | -571.522% |
| Foghorn Therapeutics Inc. | -104.45 Million USD | -319.48% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -1606.793% |
| Theravance Biopharma, Inc. | -40.86 Million USD | -972.18% |
| Ultragenyx Pharmaceutical Inc. | -516.45 Million USD | 15.158% |
| Metagenomi, Inc. Common Stock | -56.02 Million USD | -682.15% |
| BioCryst Pharmaceuticals, Inc. | -116.33 Million USD | -276.643% |
| Gain Therapeutics, Inc. | -22.16 Million USD | -1876.44% |
| Cartesian Therapeutics, Inc. | -235.06 Million USD | -86.404% |
| NexImmune, Inc. | -28.16 Million USD | -1455.579% |
| Creative Medical Technology Holdings, Inc. | -5.52 Million USD | -7829.856% |
| Marker Therapeutics, Inc. | -11.79 Million USD | -3615.722% |
| Regeneron Pharmaceuticals, Inc. | 4.65 Billion USD | 109.414% |
| Chemomab Therapeutics Ltd. | -25.39 Million USD | -1625.614% |
| Ainos, Inc. | -8.77 Million USD | -4894.45% |
| Pluri Inc. | -20.22 Million USD | -2066.467% |
| Prothena Corporation plc | -190.1 Million USD | -130.484% |
| Adaptimmune Therapeutics plc | -128.19 Million USD | -241.79% |
| Celularity Inc. | -183.94 Million USD | -138.205% |
| Rallybio Corporation | -72.37 Million USD | -505.43% |
| Cue Biopharma, Inc. | -46.05 Million USD | -851.464% |
| MeiraGTx Holdings plc | -57.05 Million USD | -668.015% |
| Omeros Corporation | -163.61 Million USD | -167.812% |
| Humacyte, Inc. | -96.45 Million USD | -354.258% |
| Immunocore Holdings plc | -59.64 Million USD | -634.577% |
| Cocrystal Pharma, Inc. | -19.37 Million USD | -2161.862% |
| Cidara Therapeutics, Inc. | -24.36 Million USD | -1698.35% |
| Blueprint Medicines Corporation | -474.61 Million USD | 7.679% |
| CalciMedica, Inc. | -34.18 Million USD | -1181.605% |
| Cabaletta Bio, Inc. | -73.23 Million USD | -498.312% |
| Scholar Rock Holding Corporation | -168.45 Million USD | -160.116% |
| Sana Biotechnology, Inc. | -252.39 Million USD | -73.608% |
| Pulmatrix, Inc. | -12.64 Million USD | -3364.874% |
| Elicio Therapeutics, Inc. | -32.96 Million USD | -1229.151% |
| Vigil Neuroscience, Inc. | -88.46 Million USD | -395.29% |
| Intellia Therapeutics, Inc. | -506.31 Million USD | 13.459% |
| Adlai Nortye Ltd. American Depositary Shares | -101.21 Million USD | -332.908% |
| Cytokinetics, Incorporated | -456.68 Million USD | 4.054% |
| Eloxx Pharmaceuticals, Inc. | -33.37 Million USD | -1212.942% |
| Nutriband Inc. | -5.12 Million USD | -8455.0% |
| Protara Therapeutics, Inc. | -43.27 Million USD | -912.59% |
| Vor Biopharma Inc. | -114.37 Million USD | -283.111% |
| Roivant Sciences Ltd. | -996.51 Million USD | 56.03% |
| Evogene Ltd. | -23.2 Million USD | -1788.33% |
| ProKidney Corp. | -147.66 Million USD | -196.723% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -578.962% |
| BridgeBio Pharma, Inc. | -565.46 Million USD | 22.512% |
| CorMedix Inc. | -48.88 Million USD | -796.287% |
| Tango Therapeutics, Inc. | -111.75 Million USD | -292.069% |
| Galectin Therapeutics Inc. | -202 Thousand USD | -216814.851% |
| Atai Life Sciences N.V. | -36.31 Million USD | -1106.709% |
| Renovaro Biosciences Inc. | -79.51 Million USD | -451.037% |
| Aerovate Therapeutics, Inc. | -81.31 Million USD | -438.866% |
| Zentalis Pharmaceuticals, Inc. | -275.5 Million USD | -59.043% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -1325.4% |
| MediciNova, Inc. | -9.87 Million USD | -4334.912% |
| Praxis Precision Medicines, Inc. | -125.94 Million USD | -247.915% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -28534.67% |
| GeoVax Labs, Inc. | -26.66 Million USD | -1543.0% |
| Axsome Therapeutics, Inc. | -224.99 Million USD | -94.749% |
| Biomea Fusion, Inc. | -124.62 Million USD | -251.603% |
| PTC Therapeutics, Inc. | -330.34 Million USD | -32.642% |
| Mereo BioPharma Group plc | -26.05 Million USD | -1581.64% |
| Cullinan Oncology, Inc. | -190.33 Million USD | -130.204% |
| Absci Corporation | -95.45 Million USD | -359.021% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -1359.344% |
| 4D Molecular Therapeutics, Inc. | -107.11 Million USD | -309.052% |
| Dyne Therapeutics, Inc. | -233.47 Million USD | -87.672% |
| Kiniksa Pharmaceuticals, Ltd. | -22.85 Million USD | -1817.165% |
| Ventyx Biosciences, Inc. | -207.83 Million USD | -110.824% |
| Allakos Inc. | -189.91 Million USD | -130.718% |
| Imunon, Inc. | -19.87 Million USD | -2104.255% |
| Fulcrum Therapeutics, Inc. | -108.49 Million USD | -303.871% |
| Corcept Therapeutics Incorporated | 108.32 Million USD | 504.498% |
| BioAtla, Inc. | -122.24 Million USD | -258.446% |
| NLS Pharmaceutics AG | -11.79 Million USD | -3614.656% |
| Bio-Path Holdings, Inc. | -15.76 Million USD | -2680.077% |
| Allogene Therapeutics, Inc. | -300.29 Million USD | -45.913% |
| Larimar Therapeutics, Inc. | -41.44 Million USD | -957.177% |
| XOMA Corporation | -39.36 Million USD | -1013.175% |
| Kezar Life Sciences, Inc. | -99.25 Million USD | -341.461% |
| Cara Therapeutics, Inc. | -117.65 Million USD | -272.433% |
| aTyr Pharma, Inc. | -52.17 Million USD | -739.756% |
| Aligos Therapeutics, Inc. | -83.81 Million USD | -422.78% |
| Akero Therapeutics, Inc. | -148.63 Million USD | -194.803% |
| Viridian Therapeutics, Inc. | -234.56 Million USD | -86.8% |
| Eliem Therapeutics, Inc. | -13.65 Million USD | -3109.317% |
| EyeGate Pharmaceuticals, Inc. | -8.04 Million USD | -5348.292% |
| Akari Therapeutics, Plc | -16.8 Million USD | -2507.832% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 232296.115% |
| Halozyme Therapeutics, Inc. | 451.94 Million USD | 196.951% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -6758.565% |
| UroGen Pharma Ltd. | -63.83 Million USD | -586.45% |
| Sutro Biopharma, Inc. | -67.91 Million USD | -545.171% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -5932.869% |
| Orgenesis Inc. | -60.71 Million USD | -621.644% |
| Entera Bio Ltd. | -8.8 Million USD | -4876.92% |
| GH Research PLC | -41.15 Million USD | -964.729% |
| Lisata Therapeutics, Inc. | -25.51 Million USD | -1617.027% |
| Reneo Pharmaceuticals, Inc. | -82.23 Million USD | -432.837% |
| Xencor, Inc. | -125.87 Million USD | -248.1% |
| 60 Degrees Pharmaceuticals, Inc. | -1.42 Million USD | -30615.33% |
| Replimune Group, Inc. | -230.19 Million USD | -90.344% |
| Coeptis Therapeutics Holdings, Inc. | -20.15 Million USD | -2073.709% |
| Vanda Pharmaceuticals Inc. | -10.94 Million USD | -3904.46% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -6758.565% |
| Portage Biotech Inc. | -18.19 Million USD | -2307.649% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -28534.67% |
| Olema Pharmaceuticals, Inc. | -104.58 Million USD | -318.963% |
| OncoCyte Corporation | -23.12 Million USD | -1794.944% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -3777.469% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -3724.51% |
| Purple Biotech Ltd. | -22.22 Million USD | -1871.51% |
| CollPlant Biotechnologies Ltd. | -6.41 Million USD | -6735.694% |
| scPharmaceuticals Inc. | -46.06 Million USD | -851.278% |
| ProMIS Neurosciences, Inc. | -17.8 Million USD | -2360.28% |
| HilleVax, Inc. | -132.46 Million USD | -230.778% |
| NeuroSense Therapeutics Ltd. | -10.63 Million USD | -4020.831% |
| Tharimmune, Inc. | -9.3 Million USD | -4610.173% |
| Genprex, Inc. | -31.06 Million USD | -1310.689% |
| Neumora Therapeutics, Inc. Common Stock | -187.52 Million USD | -133.657% |
| Atossa Therapeutics, Inc. | -31.35 Million USD | -1297.487% |
| XTL Biopharmaceuticals Ltd. | -764 Thousand USD | -57251.832% |
| Virios Therapeutics, Inc. | 150.9 Thousand USD | 290462.085% |
| OKYO Pharma Limited | -15.74 Thousand USD | -2782648.746% |
| Savara Inc. | -59.13 Million USD | -640.987% |
| Curis, Inc. | -45.13 Million USD | -870.708% |
| Daré Bioscience, Inc. | -30.7 Million USD | -1327.187% |
| Carmell Therapeutics Corporation | -15.19 Million USD | -2784.364% |
| Achieve Life Sciences, Inc. | -26.73 Million USD | -1538.992% |
| BeiGene, Ltd. | -1.12 Billion USD | 61.038% |
| Kiromic BioPharma, Inc. | -16.3 Million USD | -2587.949% |
| Revolution Medicines, Inc. Warrant | -430.58 Million USD | -1.762% |
| Protagonist Therapeutics, Inc. | -90.34 Million USD | -385.021% |
| Erasca, Inc. | -121.31 Million USD | -261.197% |
| bluebird bio, Inc. | -167.16 Million USD | -162.123% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -9639.759% |
| BioMarin Pharmaceutical Inc. | 310.28 Million USD | 241.215% |
| DBV Technologies S.A. | -85.98 Million USD | -409.604% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -9639.759% |
| Moderna, Inc. | -3.28 Billion USD | 86.653% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -928.346% |
| Fresh Tracks Therapeutics, Inc. | -5.64 Million USD | -7657.932% |
| Acrivon Therapeutics, Inc. Common Stock | -59.85 Million USD | -632.086% |
| Travere Therapeutics, Inc. | -326.24 Million USD | -34.306% |
| Monte Rosa Therapeutics, Inc. | -137.08 Million USD | -219.623% |
| Spruce Biosciences, Inc. | -47.36 Million USD | -825.069% |
| Celldex Therapeutics, Inc. | -139.03 Million USD | -215.152% |
| Cogent Biosciences, Inc. | -205.86 Million USD | -112.848% |
| MacroGenics, Inc. | 2.01 Million USD | 21823.748% |
| RenovoRx, Inc. | -11.39 Million USD | -3746.953% |
| Adicet Bio, Inc. | -136.53 Million USD | -220.92% |
| Prime Medicine, Inc. | -193.75 Million USD | -126.141% |
| Aditxt, Inc. | -25.45 Million USD | -1621.143% |
| Adagene Inc. | -14.95 Million USD | -2830.736% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -5894.01% |
| Quantum-Si incorporated | -91.8 Million USD | -377.286% |
| Maravai LifeSciences Holdings, Inc. | 712.4 Million USD | 161.505% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 126.45 Million USD | 446.501% |
| SciSparc Ltd. | -5.28 Million USD | -8195.494% |
| Vericel Corporation | 2.86 Million USD | 15399.162% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -460121.83% |
| Minerva Neurosciences, Inc. | -21.69 Million USD | -1920.005% |
| Generation Bio Co. | -133.3 Million USD | -228.708% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -427.723% |
| Black Diamond Therapeutics, Inc. | -86.02 Million USD | -409.361% |
| Arcutis Biotherapeutics, Inc. | -227.43 Million USD | -92.657% |
| Invivyd, Inc. | -196.61 Million USD | -122.856% |
| Relay Therapeutics, Inc. | -374.15 Million USD | -17.109% |
| Quoin Pharmaceuticals, Ltd. | -9.27 Million USD | -4624.286% |
| Spero Therapeutics, Inc. | 27.15 Million USD | 1713.641% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -4160.263% |
| 2seventy bio, Inc. | -206.41 Million USD | -112.272% |
| Clene Inc. | -43.24 Million USD | -913.316% |
| Capricor Therapeutics, Inc. | -23 Million USD | -1804.335% |
| Boundless Bio, Inc. Common Stock | -48.47 Million USD | -803.868% |
| GeoVax Labs, Inc. | -26.66 Million USD | -1543.0% |
| Recursion Pharmaceuticals, Inc. | -299.56 Million USD | -46.268% |
| Citius Pharmaceuticals, Inc. | -36.72 Million USD | -1092.964% |
| Contineum Therapeutics, Inc. Class A Common Stock | 23.57 Million USD | 1958.771% |
| Relmada Therapeutics, Inc. | 4.91 Million USD | 9023.528% |
| Finch Therapeutics Group, Inc. | -32.48 Million USD | -1248.956% |
| ALX Oncology Holdings Inc. | -158.4 Million USD | -176.614% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 35.969% |
| Evaxion Biotech A/S | -21.4 Million USD | -1947.227% |
| Ocular Therapeutix, Inc. | -66.41 Million USD | -559.743% |
| Verve Therapeutics, Inc. | -217.66 Million USD | -101.3% |
| Trevena, Inc. | -35.28 Million USD | -1141.691% |
| Surrozen, Inc. | -41.13 Million USD | -965.299% |
| Tyra Biosciences, Inc. | -79.59 Million USD | -450.518% |
| Cingulate Inc. | -22.95 Million USD | -1809.06% |
| Galmed Pharmaceuticals Ltd. | -7.46 Million USD | -5772.778% |
| Unity Biotechnology, Inc. | -37.28 Million USD | -1075.249% |
| Tenax Therapeutics, Inc. | -8.22 Million USD | -5226.383% |
| Terns Pharmaceuticals, Inc. | -102.26 Million USD | -328.459% |
| ACADIA Pharmaceuticals Inc. | -67.82 Million USD | -546.008% |
| Connect Biopharma Holdings Limited | -58.37 Million USD | -650.648% |
| Clearmind Medicine Inc. | -8.71 Million USD | -4930.249% |
| Kronos Bio, Inc. | -121.83 Million USD | -259.655% |
| Bolt Biotherapeutics, Inc. | -74.34 Million USD | -489.395% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -17847.304% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -334.574% |
| Statera Biopharma, Inc. | 38.93 Million USD | 1225.385% |
| ImmunityBio, Inc. | -436.18 Million USD | -0.455% |
| Korro Bio, Inc. | -80.9 Million USD | -441.59% |
| Kineta, Inc. | -15.71 Million USD | -2688.393% |
| BioVie Inc. | -31.95 Million USD | -1271.409% |
| Codexis, Inc. | -49.28 Million USD | -789.085% |
| Celularity Inc. | -183.94 Million USD | -138.205% |
| Crinetics Pharmaceuticals, Inc. | -221.51 Million USD | -97.81% |
| Celcuity Inc. | -58.3 Million USD | -651.446% |
| Virax Biolabs Group Limited | -6.6 Million USD | -6529.724% |
| Cibus, Inc. | -314.58 Million USD | -39.284% |
| Eledon Pharmaceuticals, Inc. | - USD | Infinity% |
| IN8bio, Inc. | -28.5 Million USD | -1437.216% |
| Kodiak Sciences Inc. | -259.02 Million USD | -69.162% |
| Annexon, Inc. | -141.57 Million USD | -209.495% |
| Adverum Biotechnologies, Inc. | -112.59 Million USD | -289.14% |
| Assembly Biosciences, Inc. | -64.19 Million USD | -582.547% |
| Avalo Therapeutics, Inc. | -27.95 Million USD | -1467.405% |
| Ionis Pharmaceuticals, Inc. | -230.01 Million USD | -90.5% |
| Eyenovia, Inc. | -24.1 Million USD | -1717.669% |
| Puma Biotechnology, Inc. | 44.78 Million USD | 1078.403% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -135137.037% |
| Xilio Therapeutics, Inc. | -73.8 Million USD | -493.691% |
| Arcellx, Inc. | -64.14 Million USD | -583.09% |
| Cardiff Oncology, Inc. | -45.01 Million USD | -873.404% |
| Enanta Pharmaceuticals, Inc. | -123.47 Million USD | -254.861% |
| Regulus Therapeutics Inc. | -30.88 Million USD | -1318.846% |
| Moolec Science SA | -52.07 Million USD | -741.408% |
| Acumen Pharmaceuticals, Inc. | -51.6 Million USD | -749.064% |
| LAVA Therapeutics N.V. | -40.41 Million USD | -984.118% |
| Atea Pharmaceuticals, Inc. | -119.59 Million USD | -266.383% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -4599.228% |
| TFF Pharmaceuticals, Inc. | -20.74 Million USD | -2012.594% |
| Humacyte, Inc. | -96.45 Million USD | -354.258% |
| 89bio, Inc. | -134.46 Million USD | -225.865% |
| PMV Pharmaceuticals, Inc. | -78.87 Million USD | -455.522% |
| Avenue Therapeutics, Inc. | 4.05 Million USD | 10913.623% |
| Genelux Corporation | -24.16 Million USD | -1713.234% |
| Trevi Therapeutics, Inc. | -33.8 Million USD | -1196.355% |
| Lexicon Pharmaceuticals, Inc. | -163.46 Million USD | -168.052% |
| Notable Labs, Ltd. | -14.4 Million USD | -2942.833% |
| Liquidia Corporation | -70.05 Million USD | -525.499% |
| Mustang Bio, Inc. | -48.06 Million USD | -811.653% |
| Immunovant, Inc. | -269.97 Million USD | -62.298% |
| Quantum-Si incorporated | -91.8 Million USD | -377.286% |
| Arbutus Biopharma Corporation | -70.98 Million USD | -517.26% |
| DiaMedica Therapeutics Inc. | -19.3 Million USD | -2169.36% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -329.526% |
| Acasti Pharma Inc. | -11.3 Million USD | -3777.25% |
| MiNK Therapeutics, Inc. | -22.25 Million USD | -1869.007% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -2758.07% |
| Xenon Pharmaceuticals Inc. | -210.51 Million USD | -108.143% |
| Elevai Labs, Inc. Common Stock | -4.27 Million USD | -10160.721% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -2659.244% |
| Tempest Therapeutics, Inc. | -28.77 Million USD | -1422.686% |
| Soleno Therapeutics, Inc. | -37.03 Million USD | -1083.278% |
| PepGen Inc. | -83.58 Million USD | -424.237% |
| Moleculin Biotech, Inc. | -29.5 Million USD | -1385.114% |
| United Therapeutics Corporation | 1.38 Billion USD | 131.596% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -1813.648% |
| Solid Biosciences Inc. | -93.43 Million USD | -368.96% |
| BriaCell Therapeutics Corp. | -4.77 Million USD | -9082.57% |
| Immuneering Corporation | -58.06 Million USD | -654.671% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 13662962.488% |
| Silo Pharma, Inc. | -3.62 Million USD | -11983.346% |
| Belite Bio, Inc | -31.52 Million USD | -1289.73% |
| XOMA Corporation | -39.36 Million USD | -1013.175% |
| ARS Pharmaceuticals, Inc. | -67.44 Million USD | -549.648% |
| Bionomics Limited | -9.83 Million USD | -4354.287% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -421.722% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -1166.162% |
| uniQure N.V. | -253.1 Million USD | -73.121% |
| Cassava Sciences, Inc. | -95.68 Million USD | -357.918% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -5894.01% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -238.343% |
| Forte Biosciences, Inc. | -32.47 Million USD | -1249.164% |
| Anebulo Pharmaceuticals, Inc. | -8.05 Million USD | -5342.761% |
| Enlivex Therapeutics Ltd. | -28.21 Million USD | -1452.741% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -135137.037% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -3832.932% |
| FibroBiologics, Inc. Common Stock | -15.9 Million USD | -2655.6% |
| Altimmune, Inc. | -87.93 Million USD | -398.286% |
| Amicus Therapeutics, Inc. | -92.07 Million USD | -375.861% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -1166.162% |
| Compugen Ltd. | -12.51 Million USD | -3400.863% |
| Peak Bio, Inc. | -1356.23 USD | -32307694.401% |
| Zevra Therapeutics, Inc. | -48.59 Million USD | -801.617% |
| Benitec Biopharma Inc. | -22.49 Million USD | -1848.279% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -80.835% |
| NKGen Biotech, Inc. Common Stock | -28.54 Million USD | -1435.115% |
| Zura Bio Limited | -60.56 Million USD | -623.491% |
| PolyPid Ltd. | -20.26 Million USD | -2062.404% |
| Aileron Therapeutics, Inc. | -15.61 Million USD | -2706.431% |
| NKGen Biotech, Inc. Warrants | -28.54 Million USD | -1435.115% |
| Instil Bio, Inc. | -146.12 Million USD | -199.864% |
| argenx SE | -216.02 Million USD | -102.834% |
| Immunome, Inc. | -28.27 Million USD | -1449.885% |
| Verona Pharma plc | -52.46 Million USD | -735.121% |
| enGene Holdings Inc. Warrants | -94.77 Million USD | -362.339% |
| Shattuck Labs, Inc. | -87.61 Million USD | -400.106% |
| CervoMed Inc. | -2.17 Million USD | -20074.651% |
| LENZ Therapeutics, Inc. | -122.24 Million USD | -258.437% |
| Plus Therapeutics, Inc. | -12.69 Million USD | -3352.044% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -809.553% |
| Moolec Science SA | -52.07 Million USD | -741.408% |
| Enveric Biosciences, Inc. | -17.13 Million USD | -2456.408% |
| Design Therapeutics, Inc. | -66.32 Million USD | -560.638% |
| Leap Therapeutics, Inc. | -80.98 Million USD | -441.035% |
| NeurAxis, Inc. | -6.66 Million USD | -6474.662% |
| Seelos Therapeutics, Inc. | -37.75 Million USD | -1060.71% |
| Lumos Pharma, Inc. | -36.57 Million USD | -1098.162% |
| Achilles Therapeutics plc | -70.44 Million USD | -522.027% |
| enGene Holdings Inc. Common Stock | -94.77 Million USD | -362.339% |
| 180 Life Sciences Corp. | -22.13 Million USD | -1879.613% |
| Opiant Pharmaceuticals, Inc. | 5.82 Million USD | 7616.717% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -17847.304% |
| Nutriband Inc. | -5.12 Million USD | -8455.0% |
| ORIC Pharmaceuticals, Inc. | -109.74 Million USD | -299.249% |
| CG Oncology, Inc. Common stock | -55.43 Million USD | -690.46% |
| Fractyl Health, Inc. Common Stock | -50.55 Million USD | -766.801% |
| Rani Therapeutics Holdings, Inc. | -65.27 Million USD | -571.244% |
| MoonLake Immunotherapeutics | -54.1 Million USD | -709.774% |
| Palisade Bio, Inc. | -12.28 Million USD | -3467.853% |
| Tourmaline Bio, Inc. | -45.37 Million USD | -865.638% |
| Beam Therapeutics Inc. | -156.47 Million USD | -180.028% |
| Neurogene Inc. | -52.28 Million USD | -738.022% |
| Mirum Pharmaceuticals, Inc. | -136.49 Million USD | -221.026% |
| AEON Biopharma, Inc. | -48.36 Million USD | -806.036% |
| Sesen Bio, Inc. | -50.84 Million USD | -761.857% |
| Enliven Therapeutics, Inc. | -81.93 Million USD | -434.795% |
| Kiora Pharmaceuticals, Inc. | -12.35 Million USD | -3447.912% |
| Iovance Biotherapeutics, Inc. | -427.43 Million USD | -2.512% |
| Taysha Gene Therapies, Inc. | -105.19 Million USD | -316.521% |
| Athira Pharma, Inc. | -116.7 Million USD | -275.456% |
| Vaccinex, Inc. | -19.74 Million USD | -2118.797% |
| HCW Biologics Inc. | -23.57 Million USD | -1758.53% |
| XOMA Corporation | -39.36 Million USD | -1013.175% |
| Nektar Therapeutics | -243.1 Million USD | -80.237% |
| Arvinas, Inc. | -394.8 Million USD | -10.985% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 232296.115% |
| Merus N.V. | -149.2 Million USD | -193.665% |
| Omega Therapeutics, Inc. | -93.49 Million USD | -368.679% |
| Quince Therapeutics, Inc. | -31.26 Million USD | -1301.689% |
| Rezolute, Inc. | -68.42 Million USD | -540.381% |
| Clene Inc. | -43.24 Million USD | -913.316% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -2741.153% |
| BeyondSpring Inc. | -21.54 Million USD | -1934.206% |
| Synlogic, Inc. | -55.16 Million USD | -694.344% |
| Allarity Therapeutics, Inc. | -12.08 Million USD | -3526.318% |
| Phio Pharmaceuticals Corp. | -10.64 Million USD | -4017.346% |
| Peak Bio, Inc. | -1356.23 USD | -32307694.401% |
| Werewolf Therapeutics, Inc. | -32.46 Million USD | -1249.663% |
| Krystal Biotech, Inc. | 17.9 Million USD | 2547.319% |
| Karyopharm Therapeutics Inc. | -118.42 Million USD | -270.002% |
| SpringWorks Therapeutics, Inc. | -341.34 Million USD | -28.365% |
| Lipella Pharmaceuticals Inc. | -4.6 Million USD | -9412.091% |
| MannKind Corporation | 15.12 Million USD | 2996.213% |
| Ikena Oncology, Inc. | -74.39 Million USD | -488.959% |
| Cyclerion Therapeutics, Inc. | -12.59 Million USD | -3379.457% |
| Gyre Therapeutics, Inc. | 20.32 Million USD | 2255.596% |
| Gossamer Bio, Inc. | -172.15 Million USD | -154.524% |
| CohBar, Inc. | -12.06 Million USD | -3531.5% |
| Cognition Therapeutics, Inc. | -25.5 Million USD | -1617.7% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -1359.344% |
| Legend Biotech Corporation | -477.87 Million USD | 8.309% |
| Mural Oncology plc | -192.72 Million USD | -127.36% |
| Biora Therapeutics, Inc. | -114.05 Million USD | -284.176% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -2613.909% |
| Disc Medicine, Inc. | -91.02 Million USD | -381.371% |
| Champions Oncology, Inc. | -5.05 Million USD | -8569.727% |
| REGENXBIO Inc. | -239.46 Million USD | -82.979% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -3988.079% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -685.867% |
| Cellectar Biosciences, Inc. | -38.76 Million USD | -1030.223% |
| Edgewise Therapeutics, Inc. | -112.8 Million USD | -288.426% |
| Vaxart, Inc. | -74.72 Million USD | -486.39% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -35.2 Million USD | -1144.502% |
| Cellectis S.A. | -98.09 Million USD | -346.677% |
| Longeveron Inc. | -20.06 Million USD | -2084.287% |
| Repare Therapeutics Inc. | -114.27 Million USD | -283.44% |
| Sarepta Therapeutics, Inc. | -439.19 Million USD | 0.234% |
| Inozyme Pharma, Inc. | -74.81 Million USD | -485.692% |
| Revolution Medicines, Inc. | -430.58 Million USD | -1.762% |
| Nymox Pharmaceutical Corporation | -6.28 Million USD | -6867.213% |
| Third Harmonic Bio, Inc. | -30.78 Million USD | -1323.132% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -487.435% |
| AN2 Therapeutics, Inc. | 4.9 Million USD | 9036.733% |
| Anixa Biosciences, Inc. | -10.96 Million USD | -3896.06% |
| Vertex Pharmaceuticals Incorporated | 4.6 Billion USD | 109.515% |
| Denali Therapeutics Inc. | -179.97 Million USD | -143.463% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -460121.83% |
| Veru Inc. | -89.97 Million USD | -386.985% |
| Corvus Pharmaceuticals, Inc. | -26.87 Million USD | -1530.211% |
| Cingulate Inc. | -22.95 Million USD | -1809.06% |
| Passage Bio, Inc. | -98.34 Million USD | -345.56% |
| Context Therapeutics Inc. | -25.06 Million USD | -1648.436% |
| Exicure, Inc. | -15.53 Million USD | -2719.795% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -112.637% |
| Oramed Pharmaceuticals Inc. | -36.97 Million USD | -1085.006% |
| Scinai Immunotherapeutics Ltd. | -5.96 Million USD | -7248.611% |
| Rhythm Pharmaceuticals, Inc. | -168.46 Million USD | -160.096% |
| Nuvalent, Inc. | -149.49 Million USD | -193.105% |
| ABVC BioPharma, Inc. | -8.13 Million USD | -5287.92% |
| Carisma Therapeutics, Inc. | -85.89 Million USD | -410.126% |
| Unicycive Therapeutics, Inc. | -30.17 Million USD | -1351.945% |
| OmniAb, Inc. | -49.73 Million USD | -781.076% |
| Anew Medical, Inc. | -1.3 Million USD | -33583.466% |
| Fennec Pharmaceuticals Inc. | -12.36 Million USD | -3443.902% |
| Lipocine Inc. | -16.32 Million USD | -2584.414% |
| Lexeo Therapeutics, Inc. Common Stock | -66.67 Million USD | -557.219% |
| Nautilus Biotechnology, Inc. | -74.3 Million USD | -489.704% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -1049.045% |
| G1 Therapeutics, Inc. | -39.01 Million USD | -1023.105% |
| Bellerophon Therapeutics, Inc. | -22.18 Million USD | -1875.242% |
| Sage Therapeutics, Inc. | -545.07 Million USD | 19.613% |
| Ocugen, Inc. | -64.82 Million USD | -575.904% |
| Mind Medicine (MindMed) Inc. | -92.57 Million USD | -373.337% |
| Q32 Bio Inc. | -86.5 Million USD | -406.541% |
| Brainstorm Cell Therapeutics Inc. | -16.92 Million USD | -2488.574% |
| Alumis Inc. Common Stock | -156.89 Million USD | -179.284% |
| Equillium, Inc. | -12.13 Million USD | -3509.886% |
| Kyverna Therapeutics, Inc. | -58.47 Million USD | -649.364% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -5444.08% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -2223.146% |
| Galera Therapeutics, Inc. | -46.69 Million USD | -838.422% |
| Evelo Biosciences, Inc. | -106.34 Million USD | -312.025% |
| Comera Life Sciences Holdings, Inc. | -17.88 Million USD | -2349.701% |
| Dominari Holdings Inc. | -22.44 Million USD | -1852.62% |
| Edesa Biotech, Inc. | -8.19 Million USD | -5249.944% |
| vTv Therapeutics Inc. | -25.41 Million USD | -1624.256% |
| Bio-Techne Corporation | 326.66 Million USD | 234.135% |
| Agios Pharmaceuticals, Inc. | -384.86 Million USD | -13.85% |
| Harmony Biosciences Holdings, Inc. | 216.38 Million USD | 302.491% |
| Prelude Therapeutics Incorporated | -131.1 Million USD | -234.204% |
| Candel Therapeutics, Inc. | -37.43 Million USD | -1070.602% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -189.984% |
| Nkarta, Inc. | -120.48 Million USD | -263.682% |
| BioCardia, Inc. | -11.56 Million USD | -3690.381% |
| Iterum Therapeutics plc | -34.58 Million USD | -1167.114% |